The Geroscience Pre-Clinical and Clinical Trials Task Force, will take place on March 11, 2026, at the Johns Hopkins Bloomberg Center in Washington, DC (United States). This by-invitation only gathering will be held immediately prior to the 16th Intrinsic Capacity Frailty and Sarcopenia Research (ICFSR) Conference.

 

This exclusive Task Force meeting brings together a limited numbers of leaders from academia and industry who are advancing research in geroscience and healthy aging pre-clinical and clinical trials. Our goal is to foster strategic dialogue, encourage cross-sector collaboration, and accelerate the development of novel interventions that target the biology of aging.

 

To better understand the scope and objectives of the Task Force the program from the 2025 meeting and list of participants is HERE

 

The previous Task Force reports have been published in Nature Communications Read the article and Nature Aging Read the article. These reports provide valuable insights into the advancements in Geroscience and drug development for healthy aging.  

 

Should you be interested in presenting a short communication on innovative pre-clinical or clinical trials on geroscience and healthspan, please send your abstract and short bio (250 words maximum) by October 15, 2025 to gerosciencegtct@ant-congres.com  

If you are interested in participating please note that the registration to the Task Force is by invitation only. To be considered, please send your short bio (250 words maximum) to gerosciencegtct@ant-congres.com.

 

We look forward to your potential contribution to this important dialogue and to the advancement of scientific research in this field. 

 

The Geroscience Task Force Program Committee